A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 51,012 shares of BCRX stock, worth $382,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,012
Previous 51,012 -0.0%
Holding current value
$382,079
Previous $387,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$6.41 - $8.69 $23,415 - $31,744
3,653 Added 7.71%
51,012 $387,000
Q4 2023

Jan 30, 2024

BUY
$4.98 - $6.77 $50,228 - $68,282
10,086 Added 27.06%
47,359 $283,000
Q3 2023

Oct 25, 2023

SELL
$6.71 - $7.92 $13 - $15
-2 Reduced 0.01%
37,273 $263,000
Q2 2023

Aug 07, 2023

BUY
$6.96 - $8.81 $62,257 - $78,805
8,945 Added 31.57%
37,275 $262,000
Q1 2023

May 08, 2023

BUY
$7.94 - $11.84 $13,204 - $19,689
1,663 Added 6.24%
28,330 $236,000
Q4 2022

Feb 01, 2023

BUY
$10.5 - $14.2 $14,122 - $19,099
1,345 Added 5.31%
26,667 $306,000
Q1 2022

Apr 21, 2022

SELL
$11.56 - $19.76 $60,401 - $103,246
-5,225 Reduced 17.1%
25,322 $412,000
Q4 2021

Feb 01, 2022

BUY
$11.18 - $15.46 $41,533 - $57,433
3,715 Added 13.85%
30,547 $423,000
Q3 2021

Nov 15, 2021

BUY
$14.21 - $17.65 $937 - $1,164
66 Added 0.25%
26,832 $386,000
Q2 2021

Jul 30, 2021

BUY
$9.5 - $17.24 $22,923 - $41,600
2,413 Added 9.91%
26,766 $423,000
Q1 2021

May 03, 2021

BUY
$7.37 - $13.61 $4,156 - $7,676
564 Added 2.37%
24,353 $248,000
Q2 2020

Jul 28, 2020

BUY
$1.9 - $5.61 $11,835 - $34,944
6,229 Added 35.47%
23,789 $113,000
Q1 2020

May 06, 2020

BUY
$1.6 - $4.11 $18,227 - $46,821
11,392 Added 184.7%
17,560 $35,000
Q4 2017

Jan 31, 2018

BUY
$4.16 - $5.33 $18,166 - $23,276
4,367 Added 242.48%
6,168 $30,000
Q3 2017

Nov 08, 2017

BUY
$4.1 - $5.97 $7,384 - $10,751
1,801
1,801 $9,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.